Neuro-endocrine networks controlling immune system in health and disease

Frontiers in Immunology

Volumn 5, Issue APR, 2014, Pages

  Procaccini, Claudio ^a   Pucino, Valentina ^b   De Rosa, Veronica ^a,c   Marone, Gianni ^b   Matarese, Giuseppe ^d,e  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d UNIVERSITY OF SALERNO   (Italy)

^e IRCCS MULTIMEDICA   (Italy)

Author keywords

Autoimmunity; Leptin; Metabolism; MS; Neuro immune modulation

Indexed keywords

HLA ANTIGEN; INTERLEUKIN 2; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN; NEUROPEPTIDE; NUCLEAR FACTOR Y; SIRTUIN 1; STAT5 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNITY; AUTONOMIC NERVOUS SYSTEM; CATECHOLAMINERGIC SYSTEM; CELL COMMUNICATION; CELL PROLIFERATION; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; INFLAMMATION; MULTIPLE SCLEROSIS; NERVE CELL NETWORK; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84900858569     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00143     Document Type: Review

References (147)

1. Besedovsky HO, Del Rey AE, Sorkin E, Da Prada M, Burri R, Honegger C. The immune response evokes changes in brain noradrenergic neurons. Science (1983) 221:564-5. doi: 10.1126/science.6867729.
2. Blalock JE. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev (1989) 69:1-27.
3. Carlson SL, Felten DL, Livnat S, Felten SY. Alterations of monoamines in specific central autonomic nuclei following immunization in mice. Brain Behav Immun (1987) 1:52-63. doi:10.1016/0889-1591(87)90006-7.
4. Sundar SK, Cierpial MA, Kamaraju LS, Long S, Hsieh S, Lorenz C, et al. Human immunodeficiency virus glycoprotein (gp120) infused into rat brain induces interleukin 1 to elevate pituitary-adrenal activity and decrease peripheral cellular immune responses. Proc Natl Acad Sci U S A (1991) 88:11246-50. doi:10.1073/pnas.88.24.11246.
5. Watkins LR, Maier SF, Goehler LE. Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci (1995) 57:1011-26. doi:10.1016/0024-3205(95)02047-M.
6. Dantzer R. Innate immunity at the forefront of psychoneuroimmunology. Brain Behav Immun (2004) 18:1-6. doi:10.1016/j.bbi.2003.09.008.
7. Carr DJJ, Blalock JE. Neuropeptide hormones and receptors common to the immune and neuroendocrine systems: bidirectional pathway of intersystem communication. In: Ader R, Felten DL, Cohen N, editors. Psychoneuroimmunology. (Vol. 2), San Diego, CA: Academic Press (1991). p. 573-88.
8. Blalock JE. Shared ligands and receptors as a molecular mechanism for communication between the immune and neuroendocrine systems. Ann N Y Acad Sci (1994) 741:292-8. doi:10.1111/j.1749-6632.1994.tb23112.x.
9. Harbour DV, Smith EM, Blalock JE. Splenic lymphocyte production of an endorphin during endotoxic shock. Brain Behav Immun (1987) 1:123-33. doi:10.1016/0889-1591(87)90015-8.
10. Lolait SJ, Lim AT, Toh BH, Funder JW. Immunoreactive beta-endorphin in a subpopulation of mouse spleen macrophages. J Clin Invest (1984) 73:277-80. doi:10.1172/JCI111203.
11. Engler KL, Rudd ML, Ryan JJ, Stewart JK, Fisher-Stenger K. Autocrine actions of macrophage-derived catecholamines on interleukin-1h. J Neuroimmunol (2005) 160:87-91. doi:10.1016/j.jneuroim.2004.11.005.
12. Hattori N, Inagaki C. Immunological aspects of human growth hormone and prolactin. Domest Anim Endocrinol (1998) 15:371-5. doi:10.1016/S0739-7240(98)00019-8.
13. Schulte-Herbruggen O, Nassenstein C, Lommatzsch M, Quarcoo D, Renz H, Braun A. Tumor necrosis factor-a and interleukin-6 regulates secretion of brain-derived neurotrophic factor in human monocytes. J Neuroimmunol (2005) 160:204-9. doi:10.1016/j.jneuroim.2004.10.026.
14. Wrona D. Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. J Neuroimmunol (2006) 172:38-58. doi:10.1016/j.jneuroim.2005.10.017.
15. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav Immun (2003) 17:13-9. doi:10.1016/S0889-1591(02)00055-7.
16. Ousman SS, Kubes P. Immune surveillance in the central nervous system. Nat Neurosci (2012) 15:1096-101. doi:10.1038/nn.3161.
17. Raivich G. Like cops on the beat: the active role of resting microglia. Trends Neurosci (2005) 28:571-3. doi:10.1016/j.tins.2005.09.001.
18. Hickey WF. Basic principles of immunological surveillance of the normal central nervous system. Glia (2001) 36:118-24. doi:10.1002/glia.1101.
19. Hayes GM, Woodroofe MN, Cuzner ML. Microglia are the major cell type expressing MHC class II in human white matter. J Neurol Sci (1987) 80:25-37. doi:10.1016/0022-510X(87)90218-8.
20. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science (2005) 308:1314-8. doi:10.1126/science.1110647.
21. Akiyama H, Itagaki S, McGeer PL. Major histocompatibility complex antigen expression on rat microglia following epidural kainic acid lesions. J Neurosci Res (1988) 20:147-57. doi:10.1002/jnr.490200202.
22. Akiyama H, McGeer PL. Brain microglia constitutively express β-2 integrins. J Neuroimmunol (1990) 30:81-93. doi:10.1016/0165-5728(90)90055-R.
23. Shrikant P, Benveniste EN. The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J Immunol (1996) 157:1819-22.
24. + T lymphocyte final effector function and death. J Exp Med (1996) 184:1737-45. doi:10.1084/jem.184.5.1737.
25. Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res (1991) 28:254-60. doi:10.1002/jnr.490280213.
26. Ransohoff RM, Kivisäkk P, Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol (2003) 3:569-81. doi:10.1038/nri1130.
27. + T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci U S A (2003) 100:8389-94. doi:10.1073/pnas.1433000100.
28. Kivisäkk P, Trebst C, Liu Z, Tucky BH, Sørensen TL, Rudick RA, et al. T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking. Clin Exp Immunol (2002) 129:510-8. doi:10.1046/j.1365-2249.2002.01947.x.
29. Svenningsson A, Andersen O, Edsbagge M, Stemme S. Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid. J Neuroimmunol (1995) 63:39-46. doi:10.1016/0165-5728(95)00126-3.
30. Carrithers MD, Visintin I, Viret C, Janeway CS Jr. Role of genetic background in P selectin-dependent immune surveillance of the central nervous system. J Neuroimmunol (2002) 129:51-7. doi:10.1016/S0165-5728(02)00172-8.
31. + lymphocytes. Neuropathology (2011) 31:230-8. doi:10.1111/j.1440-1789.2010.01167.x.
32. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest (2007) 117:289-96. doi:10.1172/JCI30555.
33. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature (2003) 42:384-8. doi:10.1038/nature01339.
34. Rosas-Ballina M, Olofsson PS, Ochani M, Valdés-Ferrer SI, Levine YA, Reardon C, et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science (2011) 334:98-101. doi:10.1126/science.1209985.
35. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med (2004) 10:1216-21. doi:10.1038/nm1124.
36. Saeed RW, Varma S, Peng-Nemeroff T, Sherry B, Balakhaneh D, Huston J, et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med (2005) 201:1113-23. doi:10.1084/jem.20040463.
37. van Maanen MA, Lebre MC, van der Poll T, LaRosa GJ, Elbaum D, Vervoordeldonk MJ, et al. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum (2009) 60:114-22. doi:10.1002/art.24177.
38. van Maanen MA, Vervoordeldonk MJ, Tak PP. The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. Nat Rev Rheumatol (2009) 5:229-32. doi:10.1038/nrrheum.2009.31.
39. Holguin F, Téllez-Rojo MM, Lazo M, Mannino D, Schwartz J, Hernández M, et al. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest (2005) 127:1102-7. doi:10.1378/chest.127.4.1102.
40. Facchini M, Malfatto G, Sala L, Silvestri G, Fontana P, Lafortuna C, et al. Changes of autonomic cardiac profile after a 3-week integrated body weight reduction program in severely obese patients. J Endocrinol Invest (2003) 26:138-42.
41. Madden KS, Moynihan JA, Brenner GJ, Felten SY, Felten DL, Livnat S. Sympathetic nervous system modulation of the immune system III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J Neuroimmunol (1994) 49:77-87. doi:10.1016/0165-5728(94)90183-X.
42. Madden KS. Catecholamines, sympathetic innervation, and immunity. Brain Behav Immun (2003) 17:S5-10. doi:10.1016/S0889-1591(02)00059-4.
43. Benschop RJ, Rodriguez-Feuerhahn M, Schedlowski M. Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav Immun (1996) 10:77-91. doi:10.1006/brbi.1996.0009.
44. + T cells in vitro: a receptor mediated mechanism. Neuroimmunomodulation (2001) 9:23-33. doi:10.1159/000049004.
45. Carr L, Tucker A, Fernandez-Botran R. In vivo administration of L-DOPA or dopamine decreases the number of splenic IFN-γ producing cells. J Neuroimmunol (2003) 137:87-93. doi:10.1016/S0165-5728(03)00047-X.
46. Kelley K. Growth hormone, lymphocytes and macrophages. Biochem Pharmacol (1989) 38:705-13. doi:10.1016/0006-2952(89)90222-0.
47. Dorshkind K, Horseman ND. The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr Rev (2000) 21:292-312. doi:10.1210/er.21.3.292.
48. Carreno PC, Sacedon R, Jimenez E, Vincente A, Zapata AG. Prolactin affects both survival and differentiation of T-cell progenitors. J Neuroimmunol (2005) 160:135-45. doi:10.1016/j.jneuroim.2004.11.008.
49. Esquifino AI, Arce A, Alvarez MP, Chacon F, Brown-Borg H, Bartke A. Differential effects of light/dark recombinant human prolactin administration on the submaxillary lymph nodes and spleen activity of adult male mice. Neuroimmunomodulation (2004) 11:119-26. doi:10.1159/000075321.
50. Wyllie AH. Glucocorticoid induced thymocytes apoptosis is associated with endogenous endonuclease activation. Nature (1980) 284:555-6. doi:10.1038/284555a0.
51. Ucker DS. Cytotoxic T lymphocytes and glucocorticoids activate an endogenous suicide process in target cells. Nature (1987) 327:62-4. doi:10.1038/327062a0.
52. Sternberg EM. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol (2001) 169:429-35. doi:10.1677/joe.0.1690429.
53. Eskandari F, Sternberg EM. Neural-immune interactions in health and disease. Ann N Y Acad Sci (2002) 966:20-7. doi:10.1111/j.1749-6632.2002.tb04198.x.
54. Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol (1985) 135:755-65.
55. Bellinger DL, Lorton D, Romano T, Olschowka JA, Felten SY, Felten DL. Neuropeptide innervation of lymphoid organs. Ann N Y Acad Sci (1990) 594:17-33. doi:10.1111/j.1749-6632.1990.tb40464.x.
56. Matzinger P. An innate sense of danger. Ann N Y Acad Sci (2002) 961:341-2. doi:10.1111/j.1749-6632.2002.tb03118.x.
57. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol (2007) 81:1-5. doi:10.1189/jlb.0306164.
58. Levine JD, Khasar SG, Green PG. Neurogenic inflammation and arthritis. Ann N Y Acad Sci (2006) 1069:155-67. doi:10.1196/annals.1351.014.
59. Levite M, Chowers Y, Ganor Y, Besser M, Hershkovits R, Cahalon L. Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function. Eur J Immunol (2001) 12:3504-12. doi:10.1002/1521-4141(200112)31:12<3504::AID-IMMU3504>3.0.CO;2-F.
60. Levite M, Hart I. Immunotherapy for epilepsy. Expert Rev Neurother (2002) 2:809-14. doi:10.1586/14737175.2.6.809.
61. Levite M, Fleidervish IA, Schwarz A, Pelled D, Futerman AH. Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel. J Autoimmun (1999) 13:61-72. doi:10.1006/jaut.1999.0301.
62. Ganea D, Delgado M. The neuropeptides VIP/PACAP and T cells: inhibitors or activators? Curr Pharm Des (2003) 9:997-1004. doi:10.2174/1381612033455116.
63. Ganea D, Rodriquez R, Delgado M. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity. Cell Mol Biol (2003) 49:127-42.
64. Delgado M, Gonzalez-Rey E, Ganea D. VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells. FASEB J (2004) 18:1453-5.
65. Delgado M, Pozo D, Ganea D. The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev (2004) 56:249-90. doi:10.1124/pr.56.2.7.
66. De la Fuente M, Bernaez I, Del Rio M, Hernanz A. Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY. Involvement of protein kinase C. Immunology (1993) 80:259-65.
67. Puerto M, Guayerbas N, Alvarez P, De la Fuente M. Modulation of neuropeptide Y and norepinephrine on several leukocyte functions in adult, old and very old mice. J Neuroimmunol (2005) 165:33-40. doi:10.1016/j.jneuroim.2005.03.021.
68. Feistritzer C, Clausen J, Sturn DH, Djanani A, Gunsilius E, Wiedermann CJ, et al. Natural killer cell functions mediated by the neuropeptide substance P. Regul Pept (2003) 116:119-26. doi:10.1016/S0167-0115(03)00193-9.
69. Jing H, Yen JH, Ganea D. A novel signaling pathway mediates the inhibition of CCL3/4 expression by prostaglandin E2. J Biol Chem (2004) 279:55176-86. doi:10.1074/jbc.M409816200.
70. Gropp E, Shanabrough M, Borok E, Xu AW, Janoschek R, Buch T, et al. Agouti-related peptide-expressing neurons are mandatory for feeding. Nat Neurosci (2005) 8:1289-91. doi:10.1038/nn1548.
71. Dietrich MO, Bober J, Ferreira JG, Tellez LA, Mineur YS, Souza DO, et al. AgRP neurons regulate the development of dopamine neuronal plasticity and non food-associated behaviors. Nat Neurosci (2012) 5:1108-10. doi:10.1038/nn.3147.
72. Dietrich MO, Antunes C, Geliang G, Liu ZW, Borok E, Nie Y, et al. Agrp neurons mediate Sirt1's action on the melanocortin system and energy balance: roles for Sirt1 in neuronal firing and synaptic plasticity. J Neurosci (2010) 30:11815-25. doi:10.1523/JNEUROSCI.2234-10.2010.
73. Matarese G, Procaccini C, Menale C, Kim JG, Kim JD, Diano S, et al. Hunger-promoting hypothalamic neurons modulate effector and regulatory T-cell responses. Proc Natl Acad Sci U S A (2013) 110:6193-8. doi:10.1073/pnas.1210644110.
74. Joly-Amado A, Denis RG, Castel J, Lacombe A, Cansell C, Rouch C, et al. Hypothalamic AgRP-neurons control peripheral substrate utilization and nutrient partitioning. EMBO J (2012) 31:4276-88. doi:10.1038/emboj.2012.250.
75. Gutierrez EG, Banks WA, Kastin AJ. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol (1993) 47:169-76. doi:10.1016/0165-5728(93)90027-V.
76. Gutierrez EG, Banks WA, Kastin AJ. Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier. J Neuroimmunol (1994) 55:153-60. doi:10.1016/0165-5728(94)90005-1.
77. Weller RO, Engelhardt B, Phillips MM. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol (1996) 6:275-88. doi:10.1111/j.1750-3639.1996.tb00855.x.
78. Goehler LE, Gaykema RP, Hansen MK, Anderson K, Maier SF, Watkins LR. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton Neurosci (2000) 85:49-59. doi:10.1016/S1566-0702(00)00219-8.
79. Marvel FA, Chen C, Badr N, Gaykema RPA, Goehler LE. Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-Fos expression in central autonomic nuclei. Brain Behav Immun (2004) 18:123-34. doi:10.1016/j.bbi.2003.09.004.
80. Munck A, Guyre PM. Glucocorticoids and immune function. In: Ader R, Felten DL, Cohen N, editors. Psychoneuroimmunology. (Vol. 2), San Diego, CA: Academic Press (1991). p. 447-74.
81. Besedovsky HO, Sorkin E, Keller M, Muller J. Changes in blood hormone levels during the immune response. Proc Soc Exp Biol Med (1975) 150:466-70. doi:10.3181/00379727-150-39057.
82. Besedovsky HO, Del Rey A, Sorkin E, Dinarello CA. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science (1986) 233:652-4. doi:10.1126/science.3014662.
83. Schettini G. Interleukin-1 in the neuroendocrine system from gene to function. Prog Neuroendocrinol Immunol (1990) 3:157-66.
84. Berkenbosch F, Oers J, van Del Rey A, Tilders F, Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science (1987) 238:524-6. doi:10.1126/science.2443979.
85. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science (1987) 238:522-4. doi:10.1126/science.2821621.
86. Fontana A, Grob PJ. Astrocyte-derived interleukin-1 like factors. Lymphokine Res (1984) 3:11-6.
87. Giulian D, Baker TJ, Shih LC, Lachman LB. Interleukin-1 of the central nervous system is produced by ameboid microglia. J Exp Med (1986) 164:594-604. doi:10.1084/jem.164.2.594.
88. Breder CD, Dinarello CA, Saper CB. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science (1988) 240:321-4. doi:10.1126/science.3258444.
89. Cunninham ET, De Souza EB. Interleukin 1 receptors in the brain and endocrine tissues. Immunol Today (1993) 14:171-6.
90. Koenig JI, Snow K, Clark BD, Toni R, Cannon JG, Shaw AR, et al. Intrinsic pituitary interleukin-1 beta is induced by bacteria. Endocrinology (1990) 126:3053-8. doi:10.1210/endo-126-6-3053.
91. Gatti S, Bartfai T. Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res (1993) 624:291-4. doi:10.1016/0006-8993(93)90090-A.
92. Ching S, He L, Lai W, Quan N. IL-1 type receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system. Brain Behav Immun (2005) 19:127-37. doi:10.1016/j.bbi.2004.06.001.
93. Schiffenbauer J, Streit WJ, Butfiloski E, LaBow M, Edwards C, Moldawer LL. The induction of EAE is only partially dependent on TNF receptor signaling but require the IL-1 type I receptor. Clin Immunol (2000) 95:117-23. doi:10.1006/clim.2000.4851.
94. Bernardes-Silva M, Anthony DC, Issekutz AC, Perry VH. Recruitment of neutrophils across the blood-brain barrier: the role of E- and P-selectins. J Cereb Blood Flow Metab (2001) 21:1115-24. doi:10.1097/00004647-200109000-00009.
95. Sarder M, Saito H, Abe K. Interleukin-2 promotes survival and neurite extension of cultured neurons from fetal rat brain. Brain Res (1993) 625:347-50. doi:10.1016/0006-8993(93)91080-C.
96. Beck RD Jr, King MA, Huang Z, Petitto JM. Alterations in septohippocampal cholinergic neurons resulting from interleukin-2 gene knockout. Brain Res (2002) 955:16-23. doi:10.1016/S0006-8993(02)03295-X.
97. Beck RD Jr, King MA, Ha GK, Cushman JD, Huang Z, Petittov JM. IL-2 deficiency results in altered septal and hippocampal cytoarchitecture: relation to development and neurotrophins. J Neuroimmunol (2005) 160:146-53. doi:10.1016/j.jneuroim.2004.11.006.
98. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature (1998) 395:763-70. doi:10.1038/27376.
99. Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. Mol Aspects Med (2012) 33:35-45. doi:10.1016/j.mam.2011.10.012.
100. + effector T cell responses. J Immunol (2012) 189:2941-53. doi:10.4049/jimmunol.1200935.
101. Procaccini C, Galgani M, De Rosa V, Matarese G. Intracellular metabolic pathways control immune tolerance. Trends Immunol (2012) 33:1-7.
102. Chehab FF, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet (1996) 12:318-20. doi:10.1038/ng0396-318.
103. Bennett BD, Solar GP, Yuan JQ, Mathias J, Thomas GR, Matthews W. A role for leptin and its cognate receptor in hematopoiesis. Curr Biol (1996) 6:1170-80. doi:10.1016/S0960-9822(02)70684-2.
104. Sierra-Honigmann MR, Nath AK, Murakami C, García-Cardeña G, Papapetropoulos A, Sessa WC, et al. Biological action of leptin as an angiogenic factor. Science (1998) 28:1683-6. doi:10.1126/science.281.5383.1683.
105. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell (2000) 100:197-207. doi:10.1016/S0092-8674(00)81558-5.
106. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature (1998) 394:897-901. doi:10.1038/29795.
107. Sánchez-Margalet V, Martín-Romero C, Santos-Alvarez J, Goberna R, Najib S, Gonzalez-Yanes C. Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin Exp Immunol (2003) 133:11-9. doi:10.1046/j.1365-2249.2003.02190.x.
108. Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol (2002) 168:4018-24.
109. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, et al. Leptin regulates proinflammatory immune responses. FASEB J (1998) 1:57-65.
110. Gainsford T, Willson TA, Metcalf D, Handman E, McFarlane C, Ng A, et al. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci U S A (1996) 93:14564-8. doi:10.1073/pnas.93.25.14564.
111. Caldefie-Chezet F, Poulin A, Tridon A, Sion B, Vasson MP. Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action? J Leukoc Biol (2001) 69:414-8.
112. Caldefie-Chezet F, Poulin A, Vasson MP. Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radic Res (2003) 37:809-14. doi:10.1080/1071576031000097526.
113. Tian Z, Sun R, Wei H, Gao B. Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochem Biophys Res Commun (2002) 298:297-302. doi:10.1016/S0006-291X(02)02462-2.
114. Howard JK, Lord GM, Matarese G, Vendetti S, Ghatei MA, Ritter MA, et al. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest (1999) 104:1051-9. doi:10.1172/JCI6762.
115. De Rosa V, Procaccini C, Calì G, Pirozzi G, Fontana S, Zappacosta S, et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity (2007) 26:241-55. doi:10.1016/j.immuni.2007.01.011.
116. Procaccini C, De Rosa V, Galgani M, Abanni L, Calì G, Porcellini A, et al. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity (2010) 33:929-41. doi:10.1016/j.immuni.2010.11.024.
117. + lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol (1999) 18:394-401. doi:10.1007/s100670050125.
118. Busso N, So A, Chobaz-Péclat V, Morard C, Martinez-Soria E, Talabot-Ayer D, et al. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol (2002) 168:875-82.
119. + T cells promotes Th17 responses in systemic lupus erythematosus. J Immunol (2013) 190:3054-8. doi:10.4049/jimmunol.1203275.
120. Tarzi RM, Cook HT, Jackson I, Pusey CD, Lord GM. Leptin-deficient mice are protected from accelerated nephrotoxic nephritis. Am J Pathol (2004) 164:385-90. doi:10.1016/S0002-9440(10)63128-8.
121. Matarese G, Sanna V, Lechler RI, Sarvetnick N, Fontana S, Zappacosta S, et al. Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes (2002) 51:1356-61. doi:10.2337/diabetes.51.5.1356.
122. Garcia-Gonzalez A, Gonzalez-Lopez L, Valera-Gonzalez IC, Cardona-Muñoz EG, Salazar-Paramo M, González-Ortiz M, et al. Serum leptin levels in women with systemic lupus erythematosus. Rheumatol Int (2002) 22:138-41. doi:10.1007/s00296-002-0216-9.
123. Matarese G, Sanna V, Di Giacomo A, Lord GM, Howard JK, Bloom SR, et al. Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Eur J Immunol (2001) 31:1324-32. doi:10.1002/1521-4141(200105)31:5<1324::AID-IMMU1324>3.0.CO;2-Y.
124. Williams KC, Ulvestad E, Hickey WF. Immunology of multiple sclerosis. Clin Neurosci (1994) 2:229-45.
125. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology (1996) 46:907-11. doi:10.1212/WNL.46.4.907.
126. Salzer J, Hallmans G, Nyström M, Stenlund H, Wadell G, Sundström P. Vitamin D as a protective factor in multiple sclerosis. Neurology (2012) 79:2140-5. doi:10.1212/WNL.0b013e3182752ea8.
127. Hedström AK, Sundqvist E, Bäärnhielm M, Nordin N, Hillert J, Kockum I, et al. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain (2011) 134:653-64. doi:10.1093/brain/awq371.
128. Lassmann H, Brück W, Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med (2001) 7:115-21. doi:10.1016/S1471-4914(00)01909-2.
129. Matarese G, Di Giacomo A, Sanna V, Lord GM, Howard JK, Di Tuoro A, et al. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol (2001) 166:5909-16.
130. Sanna V, Di Giacomo A, La Cava A, Lechler RI, Fontana S, Zappacosta S, et al. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest (2003) 111:241-50. doi:10.1172/JCI200316721.
131. De Rosa V, Procaccini C, La Cava A, Chieffi P, Nicoletti GF, Fontana S, et al. Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis. J Clin Invest (2006) 116:447-55. doi:10.1172/JCI26523.
132. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med (2002) 8:500-8. doi:10.1038/nm0502-500.
133. Batocchi AP, Rotondi M, Caggiula M, Frisullo G, Odoardi F, Nociti V, et al. Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. J Neuroimmunol (2003) 139:150-4. doi:10.1016/S0165-5728(03)00154-1.
134. +CD25+ regulatory T cells. Proc Natl Acad Sci U S A (2005) 102:5150-5. doi:10.1073/pnas.0408995102.
135. + T cells through the nutrient/energy-sensing mammalian target of rapamycin signaling pathway. J Immunol (2010) 185:7474-9. doi:10.4049/jimmunol.1001674.
136. Carbone F, De Rosa V, Carrieri PB, Montella S, Bruzzese D, Porcellini A, et al. Regulatory T cell proliferative potential is impaired in human autoimmune disease. Nat Med (2014) 20:69-74. doi:10.1038/nm.3411.
137. Frisullo G, Mirabella M, Angelucci F, Caggiula M, Morosetti R, Sancricca C, et al. The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. J Neuroimmunol (2007) 192:174-83. doi:10.1016/j.jneuroim.2007.08.008.
138. Munger KL, Chitnis T, Ascherio A. Body size and risk of MS in two cohorts of US women. Neurology (2009) 73:1543-50. doi:10.1212/WNL.0b013e3181c0d6e0.
139. Hedström AK, Olsson T, Alfredsson L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler (2012) 18:1334-6. doi:10.1177/1352458512436596.
140. Hedström AK, Lima Bomfim I, Barcellos L, Gianfrancesco M, Schaefer C, Kockum I, et al. Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology (2014) 82:865-72. doi:10.1212/WNL.0000000000000203.
141. Valerio A, Ghisi V, Dossena M, Tonello C, Giordano A, Frontini A, et al. Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase-3 beta. J Biol Chem (2006) 281:12950-8. doi:10.1074/jbc.M508691200.
142. Udagawa J, Hashimoto R, Suzuki H, Hatta T, Sotomaru Y, Hioki K, et al. The role of leptin in the development of the cerebral cortex in mouse embryos. Endocrinology (2006) 147:647-58. doi:10.1210/en.2005-0791.
143. Tanaka M, Suganami T, Sugita S, Shimoda Y, Kasahara M, Aoe S, et al. Role of central leptin signaling in renal macrophage infiltration. Endocr J (2010) 57:61-72. doi:10.1507/endocrj.K09E-296.
144. Tanaka M, Suganami T, Kim-Saijo M, Toda C, Tsuiji M, Ochi K, et al. Role of central leptin signaling in the starvation-induced alteration of B-cell development. J Neurosci (2011) 31:8373-80. doi:10.1523/JNEUROSCI.6562-10.2011.
145. Tschöp J, Nogueiras R, Haas-Lockie S, Kasten KR, Castañeda TR, Huber N, et al. CNS leptin action modulates immune response and survival in sepsis. J Neurosci (2010) 30:6036-47. doi:10.1523/JNEUROSCI.4875-09.2010.
146. Kamimura D, Yamada M, Harada M, Sabharwal L, Meng J, Bando H, et al. The gateway theory: bridging neural and immune interactions in the CNS. Front Neurosci (2013) 7:204. doi:10.3389/fnins.2013.00204.
147. Piccio L, Stark JL, Cross AH. Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. J Leukoc Biol (2008) 84:940-8. doi:10.1189/jlb.0208133.